Avenue Therapeutics, Inc. ( ATXI) - Key Metrics
ATXI Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.21 | -$0.14 | -$0.14 |
| 2026Q1 | $0 | -$0.21 | -$0.13 | -$0.13 |
| 2025Q4 | $0 | -$0.23 | -$0.27 | -$0.27 |
| 2025Q3 | $0 | -$0.21 | $0.12 | $0.12 |
| 2025Q2 | $0.44 | $0.11 | -$0.06 | -$0.06 |
ATXI Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.33 |
| 2026Q1 | 0% | -0.35 |
| 2025Q4 | 0% | -0.77 |
| 2025Q3 | 0% | -0.94 |
| 2025Q2 | 0% | 0.46 |
ATXI
Price: $0.26
52 week price:
Earnings Per Share: -0.86 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 246300
Market Capitalization: 848783